Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (11-20 of 599) with videos related to

Pageof 60
Sort By:
Nucleosides, Nucleotides & Nucleic Acids|August 29, 2019
Survey of ribose ring pucker of signaling nucleosides and nucleotidesVeronica Salmaso, Kenneth A Jacobson
Molecules (Basel, Switzerland)|March 14, 2017
Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist BindingAntonella Ciancetta, Kenneth A Jacobson
Biochemical Pharmacology|December 28, 2020
Purinergic signaling in diabetes and metabolismShanu Jain, Kenneth A Jacobson
Expert Opinion on Therapeutic Patents|December 16, 2014
A Key Opinion Leader interview: insight into the research and career of Dr KA JacobsonKenneth A Jacobson, Claudia Palmer
Current Opinion in Pharmacology|March 1, 2022
Adipocyte purinergic receptors activated by uracil nucleotides as obesity and type 2 diabetes targetsShanu Jain, Kenneth A Jacobson
Frontiers in Pharmacology|February 8, 2019
Editorial: Purinergic PharmacologyFrancisco Ciruela, Kenneth A Jacobson
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2017
Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug DesignAntonella Ciancetta, Kenneth A Jacobson
Drug Development Research|January 19, 2024
Recent Developments in Selective Agonists and Antagonists Acting at Purine and Pyrimidine ReceptorsKenneth A Jacobson, Fumio Suzuki
Purinergic Signalling|September 7, 2023
Editorial: Small molecules and biologics for future purinergic therapeuticsKenneth A Jacobson, Daniela Salvemini
Expert Opinion on Therapeutic Patents|June 13, 2017
Highly selective A3 adenosine receptor agonists relieve chronic neuropathic painDaniela Salvemini, Kenneth A Jacobson
Pageof 60

Showing results (11-20 of 599) with videos related to

Sort By:
Pageof 60
Nucleosides, Nucleotides & Nucleic Acids|August 29, 2019
Survey of ribose ring pucker of signaling nucleosides and nucleotidesVeronica Salmaso, Kenneth A Jacobson
Molecules (Basel, Switzerland)|March 14, 2017
Structural Probing and Molecular Modeling of the A₃ Adenosine Receptor: A Focus on Agonist BindingAntonella Ciancetta, Kenneth A Jacobson
Biochemical Pharmacology|December 28, 2020
Purinergic signaling in diabetes and metabolismShanu Jain, Kenneth A Jacobson
Expert Opinion on Therapeutic Patents|December 16, 2014
A Key Opinion Leader interview: insight into the research and career of Dr KA JacobsonKenneth A Jacobson, Claudia Palmer
Current Opinion in Pharmacology|March 1, 2022
Adipocyte purinergic receptors activated by uracil nucleotides as obesity and type 2 diabetes targetsShanu Jain, Kenneth A Jacobson
Frontiers in Pharmacology|February 8, 2019
Editorial: Purinergic PharmacologyFrancisco Ciruela, Kenneth A Jacobson
Methods in Molecular Biology (Clifton, N.J.)|December 1, 2017
Breakthrough in GPCR Crystallography and Its Impact on Computer-Aided Drug DesignAntonella Ciancetta, Kenneth A Jacobson
Drug Development Research|January 19, 2024
Recent Developments in Selective Agonists and Antagonists Acting at Purine and Pyrimidine ReceptorsKenneth A Jacobson, Fumio Suzuki
Purinergic Signalling|September 7, 2023
Editorial: Small molecules and biologics for future purinergic therapeuticsKenneth A Jacobson, Daniela Salvemini
Expert Opinion on Therapeutic Patents|June 13, 2017
Highly selective A3 adenosine receptor agonists relieve chronic neuropathic painDaniela Salvemini, Kenneth A Jacobson
Pageof 60